Global Stool Softeners Market 2022 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2031

Stool Softeners Market 2022

The healthcare vertical is growing at a rapid pace all over. There are hordes of healthcare opportunities available. Digitization is making a constructive entry to the vertical. As such, several life sciences companies are into collaborative innovation and advancements in drug- and diagnostics-related research. As such, the Stool Softeners Market is bound to climb the digitized pedestal in the years to come

According to the American Gastroenterological Association, the prevalence of constipation is 16% in all adults and about 33.5% is attributed to population older than 60 years.

The demand for stool softeners is largely associated with the increasing incidence of constipation. Geriatric patients present a widespread presence of cases of constipation as compared to the younger population. This is due to the lack of physical activity, lack of proper diet, consumption of low-fiber foods, presence of illness and the use of prescribed drugs, which leads to a rise in demand of stool softeners in this population group. 

The prevalence rate of constipation is reported to be between 11%-38%, according to the National Institute for Clinical Excellence. Constipation due to pregnancy, and menopausal cases with fluctuations of hormonal levels has also boosted the use of stool softeners globally.

Get Free Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/32579

Furthermore, eating disorders sedentary lifestyle, stress, inadequate fluid intake and endocrine or metabolic disorders among many other factors are responsible for the uptake of stool softeners to administer relief over a short-term phase of use.

The most critical augmentative factor in the growth of demand in stool softeners is the increasing prevalence of ailments such as diabetes, anorectal disorders and hypothyroidism. According to a review in the Neurogastroenterology and Motility Journal, the effect on autonomic nerves of the colon due to changes in the vagus nerve in patients with diabetes mellitus results in constipation. 

This factor has enhanced the growth of administration of stool softeners for patients with constipation associated with diabetes and other inadequacies including neurological disorders.

North America dominates the stool softeners market due to the increasingly sedentary lifestyle as well as unbalanced or poor diet-related factors. Increasing prevalence of diabetes and associated cases of constipation has led to a significant increase in the usage of stool softeners. 

According to the CDC- National Diabetes Statistics Report for 2020, in the U.S., over 10.5% of the population have been reported to have diagnosed with diabetes. A large presence of healthcare and pharmaceutical players in this region such as Gemini Pharmaceuticals, has further augmented the growth of adoption of stool softeners.

The Regulatory Cooperation Initiative (RCI) Over-the-Counter (OTC) Products in Canada considered labelling standards for over the counter Docusate as stool softeners, enhancing the uptake for occasional relief from constipation and digestive abnormalities.

Request for Table of Content@https://www.persistencemarketresearch.com/toc/32579

The growth of stool softeners in Europe is largely attributed to the increasing presence of chronic constipation in the region. Europe reports over 17% of prevalence rate of chronic constipation, as per the Neurogastroenterology and Motility Journal. This rate is reflected due to the growing geriatric population and higher consumption of medicines, which drive the high growth rate of stool softeners in this region. 

The key companies operating in manufacturing and supply of stool softeners include, 
AstraZeneca plc
Teva Pharmaceutical Industries Ltd.
Bayer AG
Abbott Laboratories
Aristo Pharmaceuticals Ltd.
Mallinckrodt Plc.
Unipex
Hunan Warant Chiral Pharmaceutical
Boehringer Ingelheim GmbH
Takeda Pharmaceutical Company Ltd
Raptakos Brett & Co. Ltd.
Mylan N.V.
GlaxoSmithKline plc
Stadmed Pvt. Ltd.
Purdue Pharma L.P.

The key players adopt strategic acquisitions to fuel R&D activity resulting in new product innovations. For instance, Mallinckrodt plc acquired Sucampo Pharmaceuticals, Inc. in 2018 and gained rights to its commercial and developmental assets.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32579

Key Segments

By Form
Liquid
Softgel Capsule
Enema

By Mode of Administration
Oral
Rectal

By Drug Type
Generic
Branded

By Availability
Over the Counter
Prescription

By End User
Hospitals
Clinics
Research Institutes

Key Stakeholders 
Stool Softeners Market Manufacturers 
Stool Softeners Market Distributors/Traders/Wholesalers 
Stool Softeners Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

Related Reports:

Renal Anemia Treatment Market -https://www.persistencemarketresearch.com/market-research/renal-anemia-treatment-market.asp

The report on Renal Anemia Treatment further projects significant growth potential with average year-on-year growth rate pegged at 7.5% over the period of 2018-2026.

Emergency Contraceptive Pills Market -https://www.persistencemarketresearch.com/market-research/emergency-contraceptive-pills-market.asp

Global Emergency contraceptive pills market to reach US$ 1,230 million, and is expected to exhibit sluggish growth and reflect less than 3% CAGR during 2017-2022.

Contact us:

Persistence Market Research          
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.